10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-011420`
Period End Date	20141231
Filing Date	20150223
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	ameh-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 76 Cash Flow Statement 100 Stockholders Equity 15

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$40.00K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.51M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	49.13M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$12.43K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	48.63M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$24.04K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	48.63M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	49.13M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$11.46K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$42.20K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$135.98K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.66M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.43M	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$366.29K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$294.33K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.95K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$560.94K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.63K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$1.91M	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$1.39M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$211.09K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.64K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.02M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.45M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.56M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$552.56K	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.81M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$444.76K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$1.58M	USD	Point-in-time
Holdback consideration	`HoldbackConsideration`	$376.24K	USD	Point-in-time
Holdback consideration	`HoldbackConsideration`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.33M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.44M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$5.34M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$5.04M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$2.00M	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$962.98K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.45M	USD	Point-in-time
Conversion feature liability	`ConversionFeatureLiability`	$-487.63K	USD	Point-in-time
Conversion feature liability	`ConversionFeatureLiability`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$185.97K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$16.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.11M	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (NOTES 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (NOTES 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 48,634,549 and 49,134,549 shares issued and outstanding as of December 31, 2014 and March 31, 2014, respectively	`CommonStockValue`	$48.63K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 48,634,549 and 49,134,549 shares issued and outstanding as of December 31, 2014 and March 31, 2014, respectively	`CommonStockValue`	$49.13K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.34M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.08M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-18.34M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.95M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$482.15K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-408.07K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.47M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$9.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.02M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$2.83M	USD	1 Quarter
Net revenues	`Revenues`	$23.40M	USD	3 Qtrs
Net revenues	`Revenues`	$7.97M	USD	3 Qtrs
Net revenues	`Revenues`	$7.64M	USD	1 Quarter
Cost of services	`CostOfServices`	$15.51M	USD	3 Qtrs
Cost of services	`CostOfServices`	$6.75M	USD	3 Qtrs
Cost of services	`CostOfServices`	$6.09M	USD	1 Quarter
Cost of services	`CostOfServices`	$2.03M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.60M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.35M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.57M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$194.06K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$6.28K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.16K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$399.24K	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.64M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$9.17M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$24.26M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$11.34M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-859.65K	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-808.60K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.37M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.53M	USD	1 Quarter
Interest expense	`InterestExpense`	$518.51K	USD	3 Qtrs
Interest expense	`InterestExpense`	$969.06K	USD	3 Qtrs
Interest expense	`InterestExpense`	$156.26K	USD	1 Quarter
Interest expense	`InterestExpense`	$362.94K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$358.43K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$480.57K	USD	3 Qtrs
Other	`OtherNonoperatingIncome`	$-739.00	USD	1 Quarter
Other	`OtherNonoperatingIncome`	$112.65K	USD	1 Quarter
Other	`OtherNonoperatingIncome`	$6.75K	USD	3 Qtrs
Other	`OtherNonoperatingIncome`	$51.74K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$108.15K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-511.76K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-157.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-436.76K	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.88M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.42M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-965.59K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.30M	USD	3 Qtrs
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$66.65K	USD	3 Qtrs
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-800.00	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-31.94K	USD	1 Quarter
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-964.79K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.88M	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$300.14K	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$629.96K	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.99M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-964.79K	USD	1 Quarter
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-3.88M	USD	3 Qtrs
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.69M	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-33.09K	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Unrealized change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.88M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.99M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-964.79K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.72M	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	3 Qtrs
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.76M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.25M	shares	3 Qtrs
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.04M	shares	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	49.01M	shares	3 Qtrs

Cash Flow Statement 100 line items

Line Item	Tag	Value	Unit	Period
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	3 Qtrs
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-964.79K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.88M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$64.81K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$194.06K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$6.28K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$19.16K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$399.24K	USD	3 Qtrs
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-12.95K	USD	3 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	3 Qtrs
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$49.79K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$13.03K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.13M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.10M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$156.55K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$-22.20K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$91.96K	USD	3 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$169.34K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$76.89K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$288.58K	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$358.43K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$480.57K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$850.82K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-414.62K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$12.43K	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-80.30K	USD	3 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-18.01K	USD	3 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-8.48K	USD	3 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-2.74K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-6.12K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$102.69K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$606.97K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$84.71K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-831.84K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-114.92K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-854.39K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$652.32K	USD	3 Qtrs
Acquisitions, net of $660,893 of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$229.50K	USD	3 Qtrs
Acquisitions, net of $660,893 of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.08M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$438.88K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$37.21K	USD	3 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.66K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-240.16K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.67M	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	3 Qtrs
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$1.00M	USD	3 Qtrs
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$2.29M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$731.75K	USD	3 Qtrs
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$813.58K	USD	3 Qtrs
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$459.76K	USD	3 Qtrs
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	3 Qtrs
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	$586.11K	USD	3 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$600.00K	USD	3 Qtrs
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$240.00K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$303.15K	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$20.00K	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$10.00K	USD	3 Qtrs
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	$514.14K	USD	3 Qtrs
Cash payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.14M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.51M	USD	3 Qtrs
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$120.28K	USD	3 Qtrs
NET INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$413.13K	USD	3 Qtrs
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.09M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.95M	USD	Point-in-time
Interest paid	`InterestPaid`	$514.22K	USD	3 Qtrs
Interest paid	`InterestPaid`	$518.51K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$18.59K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$43.89K	USD	3 Qtrs
Acquisition related holdback liability consideration	`AcquisitionRelatedHoldbackLiabilityConsideration`	$376.24K	USD	3 Qtrs
Acquisition related holdback liability consideration	`AcquisitionRelatedHoldbackLiabilityConsideration`	-	USD	3 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$13.32K	USD	3 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	3 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$125.00K	USD	3 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	3 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	3 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$101.82K	USD	3 Qtrs
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	3 Qtrs
Acquisition related consideration fair value of membership interests issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	3 Qtrs
Acquisition related deferred tax liabilities	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	-	USD	3 Qtrs
Acquisition related deferred tax liabilities	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$172.95K	USD	3 Qtrs

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.47M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Net (loss) income	`ProfitLoss`	$-1.36M	USD	3 Qtrs
Net (loss) income	`ProfitLoss`	$-964.79K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-1.39M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-3.88M	USD	3 Qtrs
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$132.00K	USD	3 Qtrs
Contributions by non-controlling interest	`ContributionByNoncontrollingInterest`	$586.11K	USD	3 Qtrs
Distribution to non-controlling interest	`DistributionToNonControllingInterest`	$-600.00K	USD	3 Qtrs
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	3 Qtrs
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.13M	USD	3 Qtrs
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$-10.00K	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.47M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.